LIWAYWAY GUADALQUIVER: Open Payments
NPI 1396181079 · BROWNSVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 23 payments from 7 companies in 2025. Trend: 2023 $61 · 2024 $114 · 2025 $460
Food & beverage: $460
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $193 |
| ABBVIE INC. | 3 | $98 |
| Exact Sciences Corporation | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 2 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Alkermes, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $11 |
Products named: ABILIFY ASIMTUFII, VRAYLAR, Cologuard Collection Kit, COBENFY, REXULTI, CAPLYTA, ARISTADA, Auvelity.
Industry payments across TX — which companies pay providers there.
